Type 2 Diabetes Patient Activation and mHealth Interventions Decreased Cardiovascular Disease RiskNovember 11th 2022
Mobile health (mHealth) and a patient activation program could serve as a model for improving health outcomes for patients in outpatient clinical settings by decreasing atherosclerotic cardiovascular disease risk score.
Improving Risk Stratification Using AI and Social Determinants of HealthNovember 8th 2022
Prediction models combining claims data with social determinants of health and additional, more-timely data sources using artificial intelligence (AI) can better identify individuals with the highest future medical spending.
Predicting Drug-Drug and Drug-Gene Interactions in a Community Pharmacy PopulationNovember 4th 2022
The probability of drug interactions increases when genetic polymorphisms are considered, indicating that pharmacogenetic assessment may be useful in predicting the presence and severity of interactions.
Changes in Use of Low-Value Services During the COVID-19 PandemicApril 22nd 2022
Use of low-value care services during COVID-19 exhibits substantial heterogeneity but, on average, shows declines similar to the use of high-value services; low-value care use lags behind high-value care use in the rebound phase.